Melexis NV
MELE: XBRU (BEL)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| b% | LOCK|%dk^ | LOCK|f%@hn#># |
Melexis Earnings: Cycle Trough Seems Behind Already; Shares Still Offer 30% Upside
Melexis' half-year results were ahead of guidance, reaching EUR 410 million in sales versus guidance of EUR 400 million. Automotive chip inventories continue to clear across the supply chain, and Melexis received more orders than expected this quarter.
